These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24228409)

  • 1. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 2) Human leukemic stem cell].
    Akashi K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2262-6. PubMed ID: 24228409
    [No Abstract]   [Full Text] [Related]  

  • 2. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 4) The intestinal epithelial stem cells and cancer stem cells].
    Tsuchiya K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2273-8. PubMed ID: 24228411
    [No Abstract]   [Full Text] [Related]  

  • 3. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 5) Stem cell disorders and epigenetics].
    Shimono Y
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2279-83. PubMed ID: 24228412
    [No Abstract]   [Full Text] [Related]  

  • 4. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; introduction].
    Akashi K; Ueda T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2254. PubMed ID: 24228407
    [No Abstract]   [Full Text] [Related]  

  • 5. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 3) iPS cell technology for neurodegenerative disease].
    Inoue H
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2267-72. PubMed ID: 24228410
    [No Abstract]   [Full Text] [Related]  

  • 6. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 1) Abnormalities in hematopoietic stem cells: congenital immunodeficiencies].
    Hara T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2255-61. PubMed ID: 24228408
    [No Abstract]   [Full Text] [Related]  

  • 7. Can we finally target the leukemic stem cells?
    Jordan CT
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):615-20. PubMed ID: 19041600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 1) Regenerative medicine for digestive organs and kidney].
    Nakauchi H
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2225-31. PubMed ID: 24228403
    [No Abstract]   [Full Text] [Related]  

  • 9. The leukemic stem cell.
    Jordan CT
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):13-8. PubMed ID: 17336250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 4) Perspective on regenerative medicine for spinal cord injury using iPS cell--from bench to bedside].
    Nakamura M; Okano H; Toyama Y
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2247-53. PubMed ID: 24228406
    [No Abstract]   [Full Text] [Related]  

  • 11. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 3) Regenerative medicine for neurological disorders].
    Takahashi J
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2241-6. PubMed ID: 24228405
    [No Abstract]   [Full Text] [Related]  

  • 12. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 2) Clinical application of iPS cells in cardiovascular field].
    Fukuda K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2232-40. PubMed ID: 24228404
    [No Abstract]   [Full Text] [Related]  

  • 13. [The human hematopoietic stem cell, normal and leukemic].
    Gabbianelli M; Valtieri M; Peschle C
    Haematologica; 1991 Jun; 76 Suppl 3():293-302. PubMed ID: 1752525
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemic cell maturation.
    Ross DW
    Arch Pathol Lab Med; 1985 Apr; 109(4):309-13. PubMed ID: 3885897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic stem cells: a review.
    O'Brien JA; Rizzieri DA
    Cancer Invest; 2013 May; 31(4):215-20. PubMed ID: 23473080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of leukemia and leukemic stem cells (LSCs).
    Kizaki M
    Int J Hematol; 2019 Jan; 109(1):3-4. PubMed ID: 30353275
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic and epigenetic alterations that drive leukemic stem cell self-renewal.
    van den Boom V; Horton SJ; Schuringa JJ
    J Stem Cells; 2012; 7(3):155-79. PubMed ID: 23619382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemic stem cells and the curability of leukemias.
    Jasmin C
    Leuk Res; 1988; 12(9):703-5. PubMed ID: 3193809
    [No Abstract]   [Full Text] [Related]  

  • 19. Considerations for targeting malignant stem cells in leukemia.
    Guzman ML; Jordan CT
    Cancer Control; 2004; 11(2):97-104. PubMed ID: 15024346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; introduction].
    Tsubouchi H; Fukuda K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2224. PubMed ID: 24228402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.